LINK:

With there being a vast variation in gynecological tumor types, physicians will need to review and ensure that the responsible MDs provide the patient with NCCN, SG, and WHO guideline appropriate care. Pathology and imagine reviewed for each tumor to determine typical and atypical features that might influence treatment in gynecological cancers.

OBJECTIVES: Upon completion of this activity, the participant should be able to – 1) Decide when surgery, chemo, and/or radiation should be used for treatment for the specific patients, 2) Introduce new pathological tests that can provide prognostic indicators for treatment decisions, 3) Identify new drugs and or treatment modalities and formulate the best treatment plan for patient cases discussed.

PLANNER/MODERATOR DISCLOSURE: Eric Koon, MD and Laura Devine, MD, have no relevant financial relationship(s) with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION:  The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABS CC:  Successful completion of this CME activity enables the learner to earn credit toward the CME requirement of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

For information, please contact Alison Porter at Alison.Porter@BSWHealth.org